By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



7000 Shoreline Court
Suite 371
South San Francisco  California  94080  U.S.A.
Phone: 650-266-1120 Fax: 650-266-1130




Company News
Achaogen (AKAO) Announces Fourth Quarter And Full Year 2014 Results 3/17/2015 7:37:53 AM
Achaogen (AKAO) Announces Appointment Of Kent Lieginger And Alan Colowick To Board Of Directors 3/13/2015 8:06:32 AM
Achaogen (AKAO) To Present At The Jefferies and Co. 2015 Antibiotic Summit On March 18, 2015 3/13/2015 8:00:47 AM
Achaogen (AKAO) To Present At The Cowen and Company 35th Annual Health Care Conference On March 3, 2015 2/25/2015 7:57:54 AM
Achaogen (AKAO) Announces Plazomicin Granted QIDP Designation By FDA 1/8/2015 7:59:30 AM
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance 11/18/2014 12:59:33 PM
Achaogen (AKAO) Announces Third Quarter 2014 Results 11/10/2014 7:53:37 AM
Achaogen (AKAO) To Present At 2014 Credit Suisse Healthcare Conference 10/29/2014 7:23:40 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $4 Million From Achaogen (AKAO) For The Initiation Of A Phase 3 Study Of Plazomicin 9/17/2014 8:30:18 AM
Achaogen (AKAO) Announces First Patient Enrollment In A Phase 3 Clinical Trial Of Plazomicin To Treat Infections Caused By Carbapenem-Resistant Enterobacteriaceae (CRE) 9/17/2014 7:48:43 AM